February 3, 2010
The January 2010 issue of the Patented Medicine Prices Review Board’s NEWSletter is available.

February 1, 2010
Health Canada has issued a Departmental Statement regarding a National Association of Pharmacy Regulatory Authorities (NAPRA) resolution on Unlicensed Natural Health Products.

January 30, 2010
The draft screening assessment reports and risk management scopes for 14 substances assessed in Batch 8 of the Chemicals Management Plan have been released.

January 29, 2010
The Guidance document entitled, “Annex 13 to the Current Edition of the Good Manufacturing Practices Guidelines Drugs Used in Clinical Trials (GUI-0036)”, has been updated.

January 27, 2010
Health Canada has opened a consultation to provide an opportunity for comment on the proposed addition of four medicinal ingredients to Part I of Schedule F to the Food and Drug Regulations.

January 26, 2010
The Natural Health Products Directorate has released its Status of Applications Quarterly Report-Quarter 3 (Fiscal year 2009-10).

January 21, 2010
A Summary Report is available of the Post-Market Reporting Compliance Inspections conducted from September 1, 2005 to March 31, 2008.

January 19, 2010
The Therapeutic Products Directorate (TPD) and the Biologics and Genetic Therapies Directorate (BGTD) are pleased to announce the release of the results of the evaluation of phase I of the Summary Basis of Decision (SBD) project.